IP Library Granted Patent US 7,670,616
Granted Patent B2
US 7,670,616 · App. 11/060,279 · Granted Mar 2, 2010

Hydrogel forming system comprising PEG derivative precursor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,616
App. No.
11/060,279
Granted
Mar 2, 2010
Kind
B2
Abstract

Variation in precursor ratio and mass of double bond functionalized polyhydric alcohol precursor and polyethylene glycol diacrylate precursor provide a wide range of release rates of drug or other biologically active agent from hydrogel formed therefrom.

Claims (15)

1. A biodegradable hydrogel forming system comprising a hydrophobic component containing at least one unsaturated group terminal moiety and a hydrophilic component which is poly(ethylene glycol) diacrylate where the hydrophobic component and hydrophilic component constitute different compounds from one another.

2. The biodegradable hydrogel forming system of claim 1 where the weight ratio of said hydrophobic component to the weight ratio of said hydrophilic component ranges from 1:99 to 99:1, for example from 80:20 to 20:80.

3. The biodegradable hydrogel forming system of claim 2 where said hydrophobic component is a biodegradable polyhydric alcohol ester where the acyl moieties of the ester originate from aliphatic homopolymer or copolymer polyester which contains free hydroxyl at its terminal end where some or each of the acyl moieties are functionalized to incorporate an unsaturated terminal moiety and where the weight average molecular weight of the ester ranges from 1,000 to 80,000.

4. The biodegradable hydrogel forming system of claim 3 where alcohol moiety of the polyhydric alcohol ester originates from a polyhydric alcohol containing from 3 to 6 hydroxyl groups.

5. The biodegradable hydrogel forming system of claim 4 where unsaturated group terminal moiety is a 2-carboxy ethenyl group.

6. The biodegradable hydrogel forming system of claim 4 where each acyl moiety of the said polyhydric alcohol ester is poly(epsilon-caprolactone) where some or each free hydroxyl is functionalized to provide unsaturated group terminal moiety which is a 2-carboxy ethenyl group.

7. The biodegradable hydrogel forming system of claim 6 where the alcohol moiety of the polyhydric alcohol ester originates from glycerol.

8. The biodegradable hydrogel forming system of claim 7 where the poly(ethylene glycol) diacrylate has the formula:

where n ranges from 8 to 400.

9. The biodegradable hydrogel forming system of claim 2 where the poly(ethylene glycol) diacrylate has the formula:

where n ranges from 8 to 400.

10. Biodegradable hydrogel formed from the hydrogel forming system of claim 9 .

11. Biodegradable hydrogel formed from the hydrogel forming system of claim 8 .

12. Delivery system comprising the biodegradable hydrogel of claim 10 entrapping or covalently bonded to drug or other biologically active agent to be delivered and/or released.

13. Delivery and/or release system comprising the biodegradable hydrogel of claim 11 entrapping or covalently bonded to drug or other biologically active agent to be delivered and/or released.

Assignments (2)
SECURITY AGREEMENT Recorded Jun 20, 2008
From: MEDIVAS, LLC
To: SATOMI, HAJIME
Reel/Frame 021127/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2005
From: WU, DAQING; CHU, CHI-CHANG
To: CORNELL RESEARCH FOUNDATION, INC.
Reel/Frame 016305/0378 →